You are here

reldesemtiv

As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate

Clinical Trials Arena

Mon, 04/24/23 - 11:23 am

clinical trials

Cytokinetics’ pipeline tumble continues after ALS med flops in phase 3 interim look

Fierce Biotech

Sun, 04/2/23 - 04:00 pm

clinical trials

Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS

Endpoints

Sun, 05/5/19 - 06:59 pm

clinical trials

After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom

Endpoints

Mon, 06/18/18 - 10:00 am

clinical trials

spinal muscular atrophy